Literature DB >> 29378960

Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Aβ by multiple endoproteolytic cleavages within the β-sheet domain.

Santiago Solé-Domènech1, Ana V Rojas2, Gia G Maisuradze2, Harold A Scheraga3, Peter Lobel4,5, Frederick R Maxfield6.   

Abstract

Accumulation of amyloid-beta (Aβ), which is associated with Alzheimer's disease, can be caused by excess production or insufficient clearance. Because of its β-sheet structure, fibrillar Aβ is resistant to proteolysis, which would contribute to slow degradation of Aβ plaques in vivo. Fibrillar Aβ can be internalized by microglia, which are the scavenger cells of the brain, but the fibrils are degraded only slowly in microglial lysosomes. Cathepsin B is a lysosomal protease that has been shown to proteolyze fibrillar Aβ. Tripeptidyl peptidase 1 (TPP1), a lysosomal serine protease, possesses endopeptidase activity and has been shown to cleave peptides between hydrophobic residues. Herein, we demonstrate that TPP1 is able to proteolyze fibrillar Aβ efficiently. Mass spectrometry analysis of peptides released from fibrillar Aβ digested with TPP1 reveals several endoproteolytic cleavages including some within β-sheet regions that are important for fibril formation. Using molecular dynamics simulations, we demonstrate that these cleavages destabilize fibrillar β-sheet structure. The demonstration that TPP1 can degrade fibrillar forms of Aβ provides insight into the turnover of fibrillar Aβ and may lead to new therapeutic methods to increase degradation of Aβ plaques.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-beta plaques; lysosomal enzyme tripeptidyl peptidase 1; mass spectrometry; molecular dynamics simulations

Mesh:

Substances:

Year:  2018        PMID: 29378960      PMCID: PMC5816203          DOI: 10.1073/pnas.1719808115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  How main-chains of proteins explore the free-energy landscape in native states.

Authors:  Patrick Senet; Gia G Maisuradze; Colette Foulie; Patrice Delarue; Harold A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

2.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology.

Authors:  Reisuke H Takahashi; Teresa A Milner; Feng Li; Ellen E Nam; Mark A Edgar; Haruyasu Yamaguchi; M Flint Beal; Huaxi Xu; Paul Greengard; Gunnar K Gouras
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells.

Authors:  D M Paresce; H Chung; F R Maxfield
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

4.  The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.

Authors:  L Lin; I Sohar; H Lackland; P Lobel
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

5.  Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates.

Authors:  Yu Tian; Istvan Sohar; John W Taylor; Peter Lobel
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

6.  Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.

Authors:  J Ezaki; M Takeda-Ezaki; K Oda; E Kominami
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

7.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils.

Authors:  Amitabha Majumdar; Dana Cruz; Nikiya Asamoah; Adina Buxbaum; Istvan Sohar; Peter Lobel; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

9.  Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.

Authors:  Vincent Boissonneault; Mohammed Filali; Martine Lessard; Jane Relton; Gordon Wong; Serge Rivest
Journal:  Brain       Date:  2009-01-17       Impact factor: 13.501

10.  Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease.

Authors:  Yiling Xiao; Buyong Ma; Dan McElheny; Sudhakar Parthasarathy; Fei Long; Minako Hoshi; Ruth Nussinov; Yoshitaka Ishii
Journal:  Nat Struct Mol Biol       Date:  2015-05-04       Impact factor: 15.369

View more
  9 in total

1.  Potential Effects of Aspirin on Lysosomal Biogenesis and Amyloid-β Clearance: An Old Drug and Novel Insights in Alzheimer's Disease Therapy.

Authors:  Helen M Melo
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

Review 2.  Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Authors:  Yasir H Qureshi; Penelope Baez; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2020-09-14       Impact factor: 4.272

3.  Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease).

Authors:  Miriam Sindelar; Jonathan P Dyke; Ruba S Deeb; Dolan Sondhi; Stephen M Kaminsky; Barry E Kosofsky; Douglas J Ballon; Ronald G Crystal; Steven S Gross
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

4.  Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model.

Authors:  Sujyoti Chandra; Avik Roy; Malabendu Jana; Kalipada Pahan
Journal:  Neurobiol Dis       Date:  2018-12-19       Impact factor: 5.996

5.  Spontaneous Isomerization of Long-Lived Proteins Provides a Molecular Mechanism for the Lysosomal Failure Observed in Alzheimer's Disease.

Authors:  Tyler R Lambeth; Dylan L Riggs; Lance E Talbert; Jin Tang; Emily Coburn; Amrik S Kang; Jessica Noll; Catherine Augello; Byron D Ford; Ryan R Julian
Journal:  ACS Cent Sci       Date:  2019-08-07       Impact factor: 14.553

6.  CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status.

Authors:  Ruocheng Dong; Burcu F Darst; Yuetiva Deming; Yue Ma; Qiongshi Lu; Henrik Zetterberg; Kaj Blennow; Cynthia M Carlsson; Sterling C Johnson; Sanjay Asthana; Corinne D Engelman
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-01

Review 7.  Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection.

Authors:  Madeleine R Brown; Sheena E Radford; Eric W Hewitt
Journal:  Front Mol Neurosci       Date:  2020-11-26       Impact factor: 5.639

8.  The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.

Authors:  Eleanor Drummond; Tomas Kavanagh; Geoffrey Pires; Mitchell Marta-Ariza; Evgeny Kanshin; Shruti Nayak; Arline Faustin; Valentin Berdah; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2022-04-13       Impact factor: 7.578

9.  A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses.

Authors:  Huan Du; Man Ying Wong; Tingting Zhang; Mariela Nunez Santos; Charlene Hsu; Junke Zhang; Haiyuan Yu; Wenjie Luo; Fenghua Hu
Journal:  Life Sci Alliance       Date:  2021-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.